Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BIRT 2584XX dose-ranging placebo-controlled trial in moderate to severe plaque psoriasis
2007-004328-18Phase 2Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Nov 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of BIRT 2584 XX in plaque psoriasis (4 arms), sponsored by Boehringer Ingelheim. Primary endpoint: PASI75 at week 12. Started Nov 2007; status: completed.
02
Drugs
BIRT 2584 XX
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2007-004328-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004328-18.